These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8878590)

  • 21. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
    Balzli CL; Caballero AR; Tang A; Weeks AC; O'Callaghan RJ
    J Cataract Refract Surg; 2010 Dec; 36(12):2160-7. PubMed ID: 21111321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new small animal model for simulating a two-stage-revision procedure in implant-related methicillin-resistant Staphylococcus aureus bone infection.
    Brunotte M; Rupp M; Stötzel S; Sommer U; Mohammed W; Thormann U; Heiss C; Lips KS; Domann E; Alt V
    Injury; 2019 Nov; 50(11):1921-1928. PubMed ID: 31451184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.
    Stahlmann R; Zippel U; Förster C; Schwabe R; Shakibaei M; Merker HJ; Borner K
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1470-5. PubMed ID: 9624496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.
    Ballow CH; Jones RN; Johnson DM; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):173-86. PubMed ID: 9401810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.
    Liu W; Liu QF; Perkins R; Drusano G; Louie A; Madu A; Mian U; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1417-23. PubMed ID: 9624487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathodic Electrical Stimulation Combined With Vancomycin Enhances Treatment of Methicillin-resistant Staphylococcus aureus Implant-associated Infections.
    Nodzo S; Tobias M; Hansen L; Luke-Marshall NR; Cole R; Wild L; Campagnari AA; Ehrensberger MT
    Clin Orthop Relat Res; 2015 Sep; 473(9):2856-64. PubMed ID: 25825157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Smith KR; Cobbs CG
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
    Frosco MB; Melton JL; Stewart FP; Kulwich BA; Licata L; Barrett JF
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2529-34. PubMed ID: 8913458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit.
    Gaudin A; Amador Del Valle G; Hamel A; Le Mabecque V; Miegeville AF; Potel G; Caillon J; Jacqueline C
    Lett Appl Microbiol; 2011 Mar; 52(3):253-7. PubMed ID: 21204878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sparfloxacin on Staphylococcus aureus adhesiveness and phagocytosis.
    Desnottes JF; Diallo N
    J Antimicrob Chemother; 1994 Apr; 33(4):737-46. PubMed ID: 8056692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice.
    Nakata K; Okazaki Y; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1757-62. PubMed ID: 7986006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.
    Entenza JM; Marchetti O; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1889-94. PubMed ID: 9687379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathodic Voltage-controlled Electrical Stimulation Plus Prolonged Vancomycin Reduce Bacterial Burden of a Titanium Implant-associated Infection in a Rodent Model.
    Nodzo SR; Tobias M; Ahn R; Hansen L; Luke-Marshall NR; Howard C; Wild L; Campagnari AA; Ehrensberger MT
    Clin Orthop Relat Res; 2016 Jul; 474(7):1668-75. PubMed ID: 26801677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective, randomized study of pefloxacin versus teicoplanin in the treatment of gram-positive coccal infections in cancer patients: early termination due to emergence of resistance to fluoroquinolones.
    Aoun M; Van der Auwera P; Varthalitis I; Bourguignon AM; Janssen M; Daneau D; Meunier F
    Support Care Cancer; 1994 May; 2(3):191-6. PubMed ID: 8032706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of infections of osteoarticular prosthesis.
    Barberán J
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():93-101. PubMed ID: 16669932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.
    Moreau NJ; Houot S; Joly-Guillou ML; Bergogne-Bérézin E
    J Antimicrob Chemother; 1996 Dec; 38(6):1079-83. PubMed ID: 9023657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA.
    Swoboda S; Helbig L; Kommerell M; Simank HG; Kees F; Geiss HK; Hoppe-Tichy T; Schröder K
    Pharmazie; 2009 Jun; 64(6):407-9. PubMed ID: 19618680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.